Literature DB >> 9503274

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease.

J A Molina1, F de Bustos, F J Jiménez-Jiménez, J Benito-León, M Ortí-Pareja, T Gasalla, A Tallón-Barranco, J A Navarro, J Arenas, R Enríquez-de-Salamanca.   

Abstract

We compared CSF and serum levels, and the CSF/serum ratio of alpha-tocopherol (vitamin E), measured by HPLC, in 34 patients with Parkinson's disease (PD) and 47 controls. CSF and serum vitamin E levels were correlate. The mean CSF and serum vitamin E levels, and the CSF/serum ratio of PD patients did not differ significantly between the groups. There was no influence of antiparkinsonian therapy on CSF vitamin E levels. CSF vitamin E levels did not correlate with age, age at onset, duration of the disease, scores of the Unified Parkinson Disease Rating Scale of the Hoehn and Yahr staging in the PD group. These results suggest that CSF vitamin E concentrations are unrelated with the risk for PD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9503274     DOI: 10.1007/BF01294729

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  27 in total

1.  Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease.

Authors:  P Férnandez-Calle; J A Molina; F J Jiménez-Jiménez; A Vázquez; M Pondal; P J García-Ruiz; D G Urra; J Domingo; R Codoceo
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

2.  Premorbid dietetic habits and risk for Parkinson's disease.

Authors:  L Ayuso-Peralta; F J Jiménez-Jiménez; F Cabrera-Valdivia; J Molina; M R Javier; J De Pedro-Cuesta; C Tabernero; S Giménez-Roldán
Journal:  Parkinsonism Relat Disord       Date:  1997-01       Impact factor: 4.891

3.  Antioxidants fail to inhibit depletion of striatal dopamine by MPTP.

Authors:  R J Baldessarini; N S Kula; D Francoeur; S P Finklestein
Journal:  Neurology       Date:  1986-05       Impact factor: 9.910

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Life-style and dietary factors early and late in Parkinson's disease.

Authors:  P Vieregge; C von Maravic; H J Friedrich
Journal:  Can J Neurol Sci       Date:  1992-05       Impact factor: 2.104

6.  Follow-up study of early-life protective and risk factors in Parkinson's disease.

Authors:  L I Golbe; T M Farrell; P H Davis
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

Review 7.  The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.

Authors:  S Fahn; G Cohen
Journal:  Ann Neurol       Date:  1992-12       Impact factor: 10.422

8.  No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.

Authors:  J E Ahlskog; R J Uitti; P A Low; G M Tyce; K K Nickander; R C Petersen; E Kokmen
Journal:  Mov Disord       Date:  1995-09       Impact factor: 10.338

9.  Concentrations of vitamins A, C and E in elderly patients with Parkinson's disease.

Authors:  D King; J R Playfer; N B Roberts
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

10.  Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  T L Perry; V W Yong; S Hansen; K Jones; C Bergeron; J G Foulks; J M Wright
Journal:  J Neurol Sci       Date:  1987-11       Impact factor: 3.181

View more
  3 in total

Review 1.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

2.  The promise of neuroprotective agents in Parkinson's disease.

Authors:  Stacey E Seidl; Judith A Potashkin
Journal:  Front Neurol       Date:  2011-11-21       Impact factor: 4.003

Review 3.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.